{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:45:34Z","timestamp":1791996334252,"version":"4.4.0"},"reference-count":64,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Disruption of the microbiota resulting in pathogenicity is known as dysbiosis and is key in the pathogenesis of inflammatory bowel disease [IBD]. The microbiome of patients with IBD is characterized by depletion of commensal bacteria, in particular Bacteroidetes and the Lachnospiraceae subgroup of Firmicutes, and by the concomitant increase in Proteobacteria and the Bacillus subgroup of Firmicutes. These changes reflect a decrease in microbial diversity with a concomitant decrease in health-promoting bacteria like Faecalibacterium and Roseburia. Treatment with biologic agents has changed the natural course of disease, improving patient outcomes. Changes in gut microbiota occur under treatment with biologic agents and act towards reversal of dysbiosis. These changes are more striking in patients achieving remission and specific gut microbiota signatures may be predictive of treatment response and a step towards precision medicine, since, despite advances in medical treatment, some patients are at risk of surgery and subsequent complications such as anastomotic leakage. This review summarizes current available evidence on the interplay of gut microbiota and biologic agents, surgery, and surgical complications in patients with IBD.<\/jats:p>","DOI":"10.3390\/ijms26157066","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T15:00:42Z","timestamp":1753196442000},"page":"7066","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Interplay of Gut Microbiota, Biologic Agents, and Postoperative Anastomotic Leakage in Inflammatory Bowel Disease: A Narrative Review"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4978-1042","authenticated-orcid":false,"given":"Alexandra-Eleftheria","family":"Menni","sequence":"first","affiliation":[{"name":"Department of Surgery, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9585-517X","authenticated-orcid":false,"given":"Evdoxia","family":"Kyriazopoulou","sequence":"additional","affiliation":[{"name":"2nd Department of Critical Care Medicine, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0187-512X","authenticated-orcid":false,"given":"Eleni","family":"Karakike","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, School of Nursing, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1095-8709","authenticated-orcid":false,"given":"Georgios","family":"Tzikos","sequence":"additional","affiliation":[{"name":"Department of Surgery, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7146-4684","authenticated-orcid":false,"given":"Eirini","family":"Filidou","sequence":"additional","affiliation":[{"name":"Novo Nordisk Foundation Center for Stem Cell Medicine, reNEW, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen N, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0241-7216","authenticated-orcid":false,"given":"Katerina","family":"Kotzampassi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0140-6736(23)02586-2","article-title":"Crohn\u2019s disease","volume":"403","author":"Dolinger","year":"2024","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(23)00966-2","article-title":"Ulcerative colitis","volume":"402","author":"Honap","year":"2023","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1126\/science.1110591","article-title":"Diversity of the human intestinal microbial flora","volume":"308","author":"Eckburg","year":"2005","journal-title":"Science"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"13780","DOI":"10.1073\/pnas.0706625104","article-title":"Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases","volume":"104","author":"Frank","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e0061622","DOI":"10.1128\/spectrum.00616-22","article-title":"Dysbiosis in the Gut Microbiota in Patients with Inflammatory Bowel Disease during Remission","volume":"10","author":"Pisani","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1136\/gutjnl-2013-304833","article-title":"A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis","volume":"63","author":"Machiels","year":"2014","journal-title":"Gut"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.immuni.2018.12.018","article-title":"The Short Chain Fatty Acid Butyrate Imprints an Antimicrobial Program in Macrophages","volume":"50","author":"Schulthess","year":"2019","journal-title":"Immunity"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1097\/MEG.0000000000002818","article-title":"The role of the fecal microbiota in inflammatory bowel disease","volume":"36","author":"Khalaf","year":"2024","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"fuad039","DOI":"10.1093\/femsre\/fuad039","article-title":"Faecalibacterium: A bacterial genus with promising human health applications","volume":"47","author":"Huillet","year":"2023","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"7582","DOI":"10.1128\/AEM.02006-15","article-title":"Mucosa-associated Faecalibacterium prausnitzii phylotype richness is reduced in patients with inflammatory bowel disease","volume":"81","author":"Busquets","year":"2015","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e154722","DOI":"10.1172\/jci.insight.154722","article-title":"Human CD4+CD8\u03b1+ Tregs induced by Faecalibacterium prausnitzii protect against intestinal inflammation","volume":"7","author":"Touch","year":"2022","journal-title":"JCI Insight."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1093\/ibd\/izy182","article-title":"Faecalibacterium prausnitzii Produces Butyrate to Maintain Th17\/Treg Balance and to Ameliorate Colorectal Colitis by Inhibiting Histone Deacetylase 1","volume":"24","author":"Zhou","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-019-0258-z","article-title":"Gut microbiota-derived metabolites as key actors in inflammatory bowel disease","volume":"17","author":"Lavelle","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/apt.12365","article-title":"Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis","volume":"38","author":"Varela","year":"2013","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/ecco-jcc\/jjw051","article-title":"Anti-TNF Therapy Response in Patients with Ulcerative Colitis Is Associated with Colonic Antimicrobial Peptide Expression and Microbiota Composition","volume":"10","author":"Magnusson","year":"2016","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Alexandrescu, L., Nicoara, A.D., Tofolean, D.E., Herlo, A., Nelson Twakor, A., Tocia, C., Trandafir, A., Dumitru, A., Dumitru, E., and Aftenie, C.F. (2024). Healing from Within: How Gut Microbiota Predicts IBD Treatment Success\u2014A Systematic Review. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25158451"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Schierova, D., Roubalova, R., Kolar, M., Stehlikova, Z., Rob, F., Jackova, Z., Coufal, S., Thon, T., Mihula, M., and Modrak, M. (2021). Fecal Microbiota Changes and Specific Anti-Bacterial Response in Patients with IBD during Anti-TNF Therapy. Cells, 10.","DOI":"10.3390\/cells10113188"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"17004","DOI":"10.1038\/nmicrobiol.2017.4","article-title":"Dynamics of the human gut microbiota in inflammatory bowel disease","volume":"2","author":"Halfvarson","year":"2017","journal-title":"Nat. Microbiol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Eckenberger, J., Butler, J.C., Bernstein, C.N., Shanahan, F., and Claesson, M.J. (2022). Interactions between Medications and the Gut Microbiota in Inflammatory Bowel Disease. Microorganisms, 10.","DOI":"10.3390\/microorganisms10101963"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2287073","DOI":"10.1080\/19490976.2023.2287073","article-title":"Gut microbiota-associated predictors as biomarkers of response to advanced therapies in inflammatory bowel disease: A systematic review","volume":"15","author":"Meade","year":"2023","journal-title":"Gut Microbes."},{"key":"ref_21","first-page":"978","article-title":"Alterations in the intestinal microbiota [dysbiosis] as a predictor of relapse after infliximab withdrawal in Crohn\u2019\u2019s disease","volume":"20","author":"Rajca","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1053\/j.gastro.2023.11.304","article-title":"Dysbiosis and Associated Stool Features Improve Prediction of Response to Biological Therapy in Inflammatory Bowel Disease","volume":"166","author":"Caenepeel","year":"2024","journal-title":"Gastroenterology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e00188-17","DOI":"10.1128\/msystems.00188-17","article-title":"Gut Microbiota Offers Universal Biomarkers across Ethnicity in Inflammatory Bowel Disease Diagnosis and Infliximab Response Prediction","volume":"3","author":"Zhou","year":"2018","journal-title":"mSystem"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/ecco-jcc\/jjaa039","article-title":"Metabonomics and the Gut Microbiota Associated with Primary Response to Anti-TNF Therapy in Crohn\u2019s Disease","volume":"14","author":"Ding","year":"2020","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/ecco-jcc\/jjv119","article-title":"Anti-tumour Necrosis Factor Treatment with Adalimumab Induces Changes in the Microbiota of Crohn\u2019s Disease","volume":"9","author":"Busquets","year":"2015","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Ribaldone, D.G., Caviglia, G.P., Abdulle, A., Pellicano, R., Ditto, M.C., Morino, M., Fusaro, E., Saracco, G.M., Bugianesi, E., and Astegiano, M. (2019). Adalimumab Therapy Improves Intestinal Dysbiosis in Crohn\u2019\u2019s Disease. J. Clin. Med., 8.","DOI":"10.3390\/jcm8101646"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"913720","DOI":"10.3389\/fphar.2022.913720","article-title":"Distinct alterations of fecal microbiota refer to the efficacy of adalimumab in Crohn\u2019\u2019s disease","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13099-024-00637-5","article-title":"Dynamic changes in the gut microbiota composition during adalimumab therapy in patients with ulcerative colitis: Implications for treatment response prediction and therapeutic targets","volume":"16","author":"Oh","year":"2024","journal-title":"Gut Pathog."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"19186","DOI":"10.1038\/s41598-020-76175-2","article-title":"Mucosal microbiota and gene expression are associated with long-term remission after discontinuation of adalimumab in ulcerative colitis","volume":"10","author":"Sakurai","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1053\/j.gastro.2019.07.025","article-title":"Metabolic Functions of Gut Microbes Associate with Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases","volume":"157","author":"Aden","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e001755","DOI":"10.1136\/rmdopen-2021-001755","article-title":"Intestinal microbiota changes induced by TNF-inhibitors in IBD-related spondyloarthritis","volume":"7","author":"Ditto","year":"2021","journal-title":"RMD Open"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1093\/ibd\/izaa253","article-title":"Fecal Microbiota Alterations Associated With Clinical and Endoscopic Response to Infliximab Therapy in Crohn\u2019s Disease","volume":"26","author":"Zhuang","year":"2020","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"10016","DOI":"10.1038\/s41598-021-88823-2","article-title":"Evaluation of changes in intestinal microbiota in Crohn\u2019s disease patients after anti-TNF alpha treatment","volume":"11","author":"Iborra","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Seong, G., Kim, N., Joung, J.G., Kim, E.R., Chang, D.K., Chun, J., Hong, S.N., and Kim, Y.H. (2020). Changes in the Intestinal Microbiota of Patients with Inflammatory Bowel Disease with Clinical Remission during an 8-Week Infliximab Infusion Cycle. Microorganisms, 8.","DOI":"10.3390\/microorganisms8060874"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/ecco-jcc\/jjae084","article-title":"Gardenia Study Group. Gut Microbial Species and Endotypes Associate with Remission in Ulcerative Colitis Patients Treated with Anti-TNF or Anti-integrin Therapy","volume":"18","author":"Tamburini","year":"2024","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e0277576","DOI":"10.1371\/journal.pone.0277576","article-title":"Association between ustekinumab therapy and changes in specific anti-microbial response, serum biomarkers, and microbiota composition in patients with IBD: A pilot study","volume":"17","author":"Rob","year":"2022","journal-title":"PLoS ONE"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e02120-17","DOI":"10.1128\/mBio.02120-17","article-title":"Fecal Microbiota Signatures Are Associated with Response to Ustekinumab Therapy among Crohn\u2019s Disease Patients","volume":"9","author":"Doherty","year":"2018","journal-title":"mBio"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Xu, F., Xie, R., He, L., Wang, H., Zhu, Y., Yang, X., and Yu, H. (Endocr. Metab. Immune Disord. Drug Targets., 2025). Oral Microbiota Associated with Clinical Efficacy of Ustekinumab in Crohn\u2019s Disease, Endocr. Metab. Immune Disord. Drug Targets., Advance online publication.","DOI":"10.2174\/0118715303363951241209060903"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e0145723","DOI":"10.1128\/spectrum.01457-23","article-title":"Gut Microbiota and Metabonomic Profile Predict Early Remission to Anti-Integrin Therapy in Patients with Moderate to Severe Ulcerative Colitis","volume":"11","author":"Liu","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.chom.2017.04.010","article-title":"Gut Microbiota Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases","volume":"21","author":"Ananthakrishnan","year":"2017","journal-title":"Cell Host Microbe"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1186\/s12866-024-03705-7","article-title":"Reduced gut microbiota diversity in ulcerative colitis patients with latent tuberculosis infection during vedolizumab therapy: Insights on prophylactic anti-tuberculosis effects","volume":"24","author":"Hu","year":"2024","journal-title":"BMC Microbiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/j.cgh.2020.10.039","article-title":"Contemporary Risk of Surgery in Patients With Ulcerative Colitis and Crohn\u2019s Disease: A Meta-Analysis of Population-Based Cohorts","volume":"19","author":"Tsai","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"101357","DOI":"10.1016\/j.jcmgh.2024.05.005","article-title":"Surgery for Crohn\u2019s Disease Is Associated With a Dysbiotic Microbiota and Metabolome: Results From Two Prospective Cohorts","volume":"18","author":"Lewis","year":"2024","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/ibd\/izaa262","article-title":"Gastrointestinal Surgery for Inflammatory Bowel Disease Persistently Lowers Microbiota and Metabolome Diversity","volume":"27","author":"Fang","year":"2021","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/DCR.0000000000000418","article-title":"Quality of Life After Total Proctocolectomy With Ileostomy or IPAA: A Systematic Review","volume":"58","author":"Murphy","year":"2015","journal-title":"Dis. Colon. Rectum."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/bjs.9697","article-title":"Systematic review of preoperative, intraoperative and postoperative risk factors for colorectal anastomotic leaks","volume":"102","author":"McDermott","year":"2015","journal-title":"Br. J. Surg."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00384-023-04416-7","article-title":"The role of preoperative mechanical bowel preparation and oral antibiotics in prevention of anastomotic leakage following restorative resection for primary rectal cancer\u2014A systematic review and meta-analysis","volume":"38","author":"Hansen","year":"2023","journal-title":"Int. J. Color. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1022603","DOI":"10.3389\/fcimb.2022.1022603","article-title":"New understanding of gut microbiota and colorectal anastomosis leak: A collaborative review of the current concepts","volume":"12","author":"Liu","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e29826","DOI":"10.1097\/MD.0000000000029826","article-title":"Role of gut microbiota in postoperative complications and prognosis of gastrointestinal surgery: A narrative review","volume":"101","author":"Shi","year":"2022","journal-title":"Medicine"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e44326","DOI":"10.1371\/journal.pone.0044326","article-title":"Intestinal tissues induce an SNP mutation in Pseudomonas aeruginosa that enhances its virulence: Possible role in anastomotic leak","volume":"7","author":"Olivas","year":"2012","journal-title":"PLoS ONE"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"286ra68","DOI":"10.1126\/scitranslmed.3010658","article-title":"Collagen degradation and MMP9 activation by Enterococcus faecalis contribute to intestinal anastomotic leak","volume":"7","author":"Shogan","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1128\/AAC.38.11.2564","article-title":"Bacteria: A major pathogenic factor for anastomotic insufficiency","volume":"38","author":"Schardey","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/gutjnl-2022-328389","article-title":"Gut microbiota influence anastomotic healing in colorectal cancer surgery through modulation of mucosal proinflammatory cytokines","volume":"72","author":"Hajjar","year":"2023","journal-title":"Gut"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1111\/codi.16733","article-title":"Anastomotic leak in colorectal cancer surgery: Contribution of gut microbiota and prediction approaches","volume":"25","author":"Caminoa","year":"2023","journal-title":"Color. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s13304-020-00720-x","article-title":"Role of preoperative gut microbiota on colorectal anastomotic leakage: Preliminary results","volume":"72","author":"Palmisano","year":"2020","journal-title":"Updates Surg."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"15335","DOI":"10.1038\/s41598-024-65320-w","article-title":"Prediction of anastomotic insufficiency based on the mucosal microbiota prior to colorectal surgery: A proof-of-principle study","volume":"14","author":"Lehr","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Lianos, G.D., Frountzas, M., Kyrochristou, I.D., Sakarellos, P., Tatsis, V., Kyrochristou, G.D., Bali, C.D., Gazouli, M., Mitsis, M., and Schizas, D. (2024). What Is the Role of the Gut Microbiota in Anastomotic Leakage After Colorectal Resection? A Scoping Review of Clinical and Experimental Studies. J. Clin. Med., 13.","DOI":"10.3390\/jcm13226634"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12893-018-0425-0","article-title":"No effect of anti-TNF-\u03b1 agents on the surgical stress response in patients with inflammatory bowel disease undergoing bowel resections: A prospective multi-center pilot study","volume":"18","author":"Qvist","year":"2018","journal-title":"BMC Surg."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1007\/s11605-016-3194-z","article-title":"Effect of Anti-TNF Agents on Postoperative Outcomes in Inflammatory Bowel Disease Patients: A Single Institution Experience","volume":"20","author":"Shwaartz","year":"2016","journal-title":"J. Gastrointest. Surg."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3109\/00365521.2012.660540","article-title":"Biologic treatment or immunomodulation is not associated with postoperative anastomotic complications in abdominal surgery for Crohn\u2019s disease","volume":"47","author":"Andersen","year":"2012","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1007\/s11605-008-0630-8","article-title":"Perioperative treatment with infliximab in patients with Crohn\u2019s disease and ulcerative colitis is not associated with an increased rate of postoperative complications","volume":"12","author":"Kunitake","year":"2008","journal-title":"J. Gastrointest. Surg."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.crohns.2013.01.019","article-title":"The risks of post-operative complications following pre-operative infliximab therapy for Crohn\u2019s disease in patients undergoing abdominal surgery: A systematic review and meta-analysis","volume":"7","author":"Rosenfeld","year":"2013","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1007\/s10620-016-4171-9","article-title":"Timing of Last Preoperative Dose of Infliximab Does Not Increase Postoperative Complications in Inflammatory Bowel Disease Patients","volume":"61","author":"Alsaleh","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1007\/s11605-019-04486-5","article-title":"Infliximab Does Not Promote the Presence of Collagenolytic Bacteria in a Mouse Model of Colorectal Anastomosis","volume":"24","author":"Gaines","year":"2020","journal-title":"J. Gastrointest. Surg."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/15\/7066\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:14:10Z","timestamp":1760033650000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/15\/7066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":64,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["ijms26157066"],"URL":"https:\/\/doi.org\/10.3390\/ijms26157066","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,22]]}}}